Products Affected - Description
Methylergonovine maleate injection
Reason for the Shortage
- Akorn could not provide a reason for the shortage of methylergonovine maleate injection.
- American Regent had methylergonovine maleate injection on back order due to manufacturing delays.
Methylergonovine maleate injection, Akorn
0.2 mg/mL, 1 mL vial (NDC 17478-0501-01)
Methylergonovine maleate injection, American Regent
0.2 mg/mL, 1 mL vial (NDC 00517-0740-20)
Estimated Resupply Dates
All presentations are currently available.
October 17, 2014; September 8, 2014; June 26, 2014; April 9, 2014; February 6, 2014; December 20, 2013; December 9, 2013; November 11, 2013; October 10, 2013; August 26, 2013; August 6, 2013; University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins